Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Press Releases

GenSight Biologics Provides Business Update and Cash Position as of September 30, 2024

  • The Pharma Data
  • October 25, 2024

GenSight Biologics Reports €3.4 Million Cash Position as of September 30, 2024, and Business Update GenSight Biologics (“GenSight” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company…

Read MoreGenSight Biologics Provides Business Update and Cash Position as of September 30, 2024
  • Press Releases

Merz Therapeutics and World Stroke Organization Launch Initiative to Enhance Stroke Treatment in Africa

  • The Pharma Data
  • October 25, 2024

Launch of Access to Health Initiative Announced at World Stroke Congress The World Stroke Organization (WSO) President, Dr. Sheila Martins, officially launched the Access to Health initiative at the annual…

Read MoreMerz Therapeutics and World Stroke Organization Launch Initiative to Enhance Stroke Treatment in Africa
  • Research

2024-2029 AI-Based Drug Repurposing Market Growth Report: Accelerating Drug Development

  • The Pharma Data
  • October 25, 2024

This study investigates the rise of AI-based drug repurposing and assesses the factors that drive or hinder its adoption. Traditional drug discovery methods have limitations that fuel interest in AI-based…

Read More2024-2029 AI-Based Drug Repurposing Market Growth Report: Accelerating Drug Development
  • Press Releases

Median Technologies Releases Q3 2024 Operational and Financial Update

  • The Pharma Data
  • October 25, 2024

eyonis™ LCS Achieves Key Milestones in REALITY Study; Upcoming Webcast Scheduled Key Highlights: Operational and Financial Overview:Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced that its Board of Directors approved the…

Read MoreMedian Technologies Releases Q3 2024 Operational and Financial Update
  • Research

GUARDIAN Study Reveals Benefits of Genome Sequencing in Newborn Screening

  • The Pharma Data
  • October 25, 2024

GeneDx’s GUARDIAN Study Reveals Promise of Whole Genome Sequencing for Newborns Recent findings published in the Journal of the American Medical Association (JAMA) underscore the limitations of traditional newborn screening…

Read MoreGUARDIAN Study Reveals Benefits of Genome Sequencing in Newborn Screening
  • Research

Havah Therapeutics Forms Clinical Advisory Board to Advance New Breast Cancer Treatment

  • The Pharma Data
  • October 25, 2024

Havah Therapeutics, a clinical-stage biopharmaceutical company focused on innovative hormonal implant therapies for breast cancer prevention and treatment, has established a Clinical Advisory Board chaired by founder Stephen Birrell, MD,…

Read MoreHavah Therapeutics Forms Clinical Advisory Board to Advance New Breast Cancer Treatment
  • News

PharmaJet Study: Tropis® Needle-Free System Boosts Polio Immunization Coverage and Cuts Costs

  • The Pharma Data
  • October 25, 2024

PharmaJet has announced compelling results from a groundbreaking implementation study in Nigeria, showing that their Tropis® ID Needle-free System significantly enhances polio immunization coverage, reduces costs, and gains widespread support…

Read MorePharmaJet Study: Tropis® Needle-Free System Boosts Polio Immunization Coverage and Cuts Costs
  • Press Releases

Shields Health and Sutter Health Expand Access to Specialty Pharmacy Services

  • The Pharma Data
  • October 25, 2024

Shields Health Solutions (Shields), a leading specialty pharmacy accelerator and a Walgreens-owned company, has expanded its partnership with Sutter Health, one of the largest nonprofit health systems in the U.S.,…

Read MoreShields Health and Sutter Health Expand Access to Specialty Pharmacy Services
  • News

Integrated Inspection and PV2 Automation Lower Pharmacy Costs

  • The Pharma Data
  • October 25, 2024

As pharmacies navigate challenging market conditions and regulatory demands, automation offers a powerful opportunity to boost efficiency and reduce costs. Pharmacy automation provider JFCRx™ has launched TruCard™, a multi-dose adherence…

Read MoreIntegrated Inspection and PV2 Automation Lower Pharmacy Costs
  • Press Releases

Groundbreaking AI-Powered Solutions for Consumer-Controlled Health Information Management

  • The Pharma Data
  • October 24, 2024

YourHealth Launches YourHealth Life: A Revolutionary Subscription-Based Health Management Tool YourHealth, a leader in consumer-controlled health applications, is thrilled to announce the launch of YourHealth Life, an innovative suite of…

Read MoreGroundbreaking AI-Powered Solutions for Consumer-Controlled Health Information Management
  • Research

Aulos Bioscience Unveils Phase 2 Data for IL-2 Antibody AU-007 at EORTC-NCI-AACR Symposium

  • The Pharma Data
  • October 24, 2024

AU-007 Showcases Unique IL-2 Class Profile with Promising Efficacy Data Aulos Bioscience, a pioneering company in the field of immuno-oncology, recently presented significant data supporting the dose selection for its…

Read MoreAulos Bioscience Unveils Phase 2 Data for IL-2 Antibody AU-007 at EORTC-NCI-AACR Symposium
  • Press Releases

Valor Compounding Pharmacy Seeks New Partnerships with Medical Practices and Hospital Systems

  • The Pharma Data
  • October 24, 2024

Valor Compounding Pharmacy Invites New Partnerships with Medical Practices and Hospital Systems Valor Compounding Pharmacy, a prominent provider of compounded medications, is excited to announce its initiative to form new…

Read MoreValor Compounding Pharmacy Seeks New Partnerships with Medical Practices and Hospital Systems
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Curocell’s RIMQARTO Injection Secures Full Regulatory Approval, Set to Enter CAR-T Market with 67% Complete Response Rate
  • TRexBio Initiates Phase 1b Study of TRB-061 with First Patient Dosed in Moderate-to-Severe Atopic Dermatitis
  • U.S. FDA Grants Priority Review to Gilead’s NDA for Once-Daily HIV Regimen Combining Bictegravir and Lenacapavir
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.